Clinical Trial Update: Dose-finding Study of WS6788A, DS37-4 and H10407 Enterotoxigenic Escherichia Coli (ETEC) Challenge Strains [Phase 1]

View source ↗

Summary

Phase 1 dose-finding study evaluating enterotoxigenic E. coli challenge strains WS6788A, DS37-4, and H10407; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea

Drugs mentioned

• DS37-4
• H10407
• WS6788A

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Diarrhea | Phase 1 | Status: COMPLETED